User menu

The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response

  • Open access
  • PDF
  • 282.83 K
  1. Glezen WP, Epidemiol Rev, 4, 25 (1982)
  2. World Health Organization., Influenza Fact Sheet (2003)
  3. Cox R. J., Brokstad K. A., Ogra P., Influenza Virus: Immunity and Vaccination Strategies. Comparison of the Immune Response to Inactivated and Live, Attenuated Influenza Vaccines, 10.1111/j.0300-9475.2004.01382.x
  4. McElhaney Janet E., The unmet need in the elderly: Designing new influenza vaccines for older adults, 10.1016/j.vaccine.2005.04.019
  5. Clements ML, J Clin Microbiol, 24, 157 (1986)
  6. Ogra P. L., Fishaut M., Gallagher M. R., Viral Vaccination Via the Mucosal Routes, 10.1093/clinids/2.3.352
  7. FRIEDE M, AGUADO M, Need for new vaccine formulations and potential of particulate antigen and DNA delivery systems, 10.1016/j.addr.2004.10.001
  8. Levine Myron M., Can needle-free administration of vaccines become the norm in global immunization?, 10.1038/nm0103-99
  9. JORDAN R, CONNOCK M, ALBON E, FRYSMITH A, OLOWOKURE B, HAWKER J, BURLS A, Universal vaccination of children against influenza: Are there indirect benefits to the community?A systematic review of the evidence, 10.1016/j.vaccine.2005.09.017
  10. Tamura Shin-ichi, Samegai Yasuo, Kurata Hideki, Nagamine Takashi, Aizawa Chikara, Kurata Takeshi, Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit, 10.1016/0264-410x(88)90140-5
  11. Gluck U, J Virol, 73, 7780 (1999)
  12. LANGLEY J, HALPERIN S, MCNEIL S, SMITH B, JONES T, BURT D, MALLETT C, LOWELL G, FRIES L, Safety and immunogenicity of a Proteosome™-trivalent inactivated influenza vaccine, given nasally to healthy adults, 10.1016/j.vaccine.2005.09.056
  13. Fujihashi Kohtaro, Koga Toshiya, van Ginkel Frederik W., Hagiwara Yukari, McGhee Jerry R., A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants, 10.1016/s0264-410x(02)00155-x
  14. Johnson P. R., Feldman S., Thompson J. M., Mahoney J. D., Wright P. F., Immunity to Influenza A Virus Infection in Young Children: A Comparison of Natural Infection, Live Cold-Adapted Vaccine, and Inactivated Vaccine, 10.1093/infdis/154.1.121
  15. Sabin A. B., Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. I. Different results with undiluted human diploid cell and chick embryo fibroblast vaccines, 10.1001/jama.249.19.2651
  16. Dilraj Athmanundh, Cutts Felicity T, Fernandez de Castro J, Wheeler Jeremy G, Brown David, Roth Cathy, Coovadia Hoosen M, Bennett John V, Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial, 10.1016/s0140-6736(99)95140-1
  17. Bellanti Joseph A, Zeligs Barbara J, Mendez-Inocencio Julia, de Lourdes Garcı́a-Garcia Ma, Islas-Romero Rocio, Omidvar Berna, Omidvar Jemal, Kim Gino, Fernandez de Castro Jorge, Sepulveda Amor Jaime, Walls Laura, Bellini William J, Valdespino-Gomez José L, Immunologic studies of specific mucosal and systemic immune responses in Mexican school children after booster aerosol or subcutaneous immunization with measles vaccine, 10.1016/j.vaccine.2003.09.032
  18. Smith Dan J., Bot Simona, Dellamary Luis, Bot Adrian, Evaluation of novel aerosol formulations designed for mucosal vaccination against influenza virus, 10.1016/s0264-410x(03)00224-x
  19. Bot Adrian I., Smith Dan J., Bot Simona, Dellamary Luis, Tarara Thomas E., Harders Shelly, Phillips William, Weers Jeffry G., Woods Catherine M., 10.1023/a:1010988311640
  20. 20 A Hensel, and W Lubitz . Vaccination by Aerosols: Modulation of Clearance Mechanisms in the Lung . Marburg/Lahn: Behring Institute Mitt, 1997 :212 -19 .
  21. Heyder J., Gebhart J., Rudolf G., Schiller C.F., Stahlhofen W., Deposition of particles in the human respiratory tract in the size range 0.005–15 μm, 10.1016/0021-8502(86)90035-2
  22. Schulz Holger, Mechanisms and factors affecting intrapulmonary particle deposition: implications for efficient inhalation therapies Holger Schulz, 10.1016/s1461-5347(98)00089-3
  23. Menzel Manuela, Muellinger Bernhard, Weber Norbert, Haeussinger Karl, Ziegler-Heitbrock Loems, Inhalative vaccination with pneumococcal polysaccharide in healthy volunteers, 10.1016/j.vaccine.2005.05.040
  24. Williams M.S., Mayner R.E., Daniel N.J., Phelan M.A., Rastogi S.C., Bozeman F.M., Ennis F.A., New developments in the measurement of the hemagglutinin content of influenza virus vaccines by single-radial-immunodiffusion, 10.1016/s0092-1157(80)80006-0
  25. Lombry Catherine, Marteleur Aline, Arras Mohammed, Lison Dominique, Louahed Jamila, Renauld Jean-Christophe, Préat Véronique, Vanbever Rita, Local and Systemic Immune Responses to Intratracheal Instillation of Antigen and DNA Vaccines in Mice, 10.1023/b:pham.0000012160.00222.55
  26. McCluskie MJ, Mol Med, 6, 867 (2000)
  27. Foster WM, J Appl Physiol, 90, 1111 (2001)
  29. Hastings RH, J Appl Physiol, 73, 1310 (1992)
  30. Marttin Emmeline, Schipper Nicolaas G.M, Verhoef J.Coos, Merkus Frans W.H.M, Nasal mucociliary clearance as a factor in nasal drug delivery, 10.1016/s0169-409x(97)00059-8
  31. Snipes M.B., Boecker B.B., McClellan R.O., Retention of monodisperse or polydisperse aluminosilicate particles inhaled by dogs, rats, and mice, 10.1016/0041-008x(83)90258-2
  32. Moller W., Mucociliary and long-term particle clearance in the airways of healthy nonsmoker subjects, 10.1152/japplphysiol.00970.2003
  33. Lombry C., Alveolar macrophages are a primary barrier to pulmonary absorption of macromolecules, 10.1152/ajplung.00260.2003
  34. Takenaka Shinji, Karg Erwin, Roth Christa, Schulz Holger, Ziesenis Axel, Heinzmann Ulrich, Schramel Peter, Heyder Joachim, Pulmonary and Systemic Distribution of Inhaled Ultrafine Silver Particles in Rats, 10.2307/3454667
  35. Moyron-Quiroz Juan E, Rangel-Moreno Javier, Kusser Kim, Hartson Louise, Sprague Frank, Goodrich Stephen, Woodland David L, Lund Frances E, Randall Troy D, Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity, 10.1038/nm1091
  36. Woodland David L., Randall Troy D., Anatomical features of anti-viral immunity in the respiratory tract, 10.1016/j.smim.2004.02.003
  37. ALPAR H, SOMAVARAPU S, ATUAH K, BRAMWELL V, Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery, 10.1016/j.addr.2004.09.004
  38. Holmgren Jan, Czerkinsky Cecil, Mucosal immunity and vaccines, 10.1038/nm1213
  39. Moran Thomas M., Park Helen, Fernandez‐Sesma Ana, Schulman Jerome L., Th2 Responses to Inactivated Influenza Virus Can Be Converted to Th1 Responses and Facilitate Recovery from Heterosubtypic Virus Infection, 10.1086/314952
  40. Constant Stephanie L., Brogdon Jennifer L., Piggott Damani A., Herrick Christina A., Visintin Irene, Ruddle Nancy H., Bottomly Kim, Resident lung antigen-presenting cells have the capacity to promote Th2 T cell differentiation in situ, 10.1172/jci200216109
  41. Jones H. P., Hodge L. M., Fujihashi K., Kiyono H., McGhee J. R., Simecka J. W., The Pulmonary Environment Promotes Th2 Cell Responses After Nasal-Pulmonary Immunization with Antigen Alone, but Th1 Responses Are Induced During Instances of Intense Immune Stimulation, 10.4049/jimmunol.167.8.4518
  42. Schmid D. Scott, Rouse Barry T., Respiratory Viral Vaccines, Mucosal Immunology (2005) ISBN:9780124915435 p.923-936, 10.1016/b978-012491543-5/50055-3
  43. O'Garra Anne, Cytokines Induce the Development of Functionally Heterogeneous T Helper Cell Subsets, 10.1016/s1074-7613(00)80533-6
  44. von Garnier C., Filgueira L., Wikstrom M., Smith M., Thomas J. A., Strickland D. H., Holt P. G., Stumbles P. A., Anatomical Location Determines the Distribution and Function of Dendritic Cells and Other APCs in the Respiratory Tract, 10.4049/jimmunol.175.3.1609
  45. Moldoveanu Z., Clements M.L., Prince S.J., Murphy B.R., Mestecky J., Human immune responses to influenza virus vaccines administered by systemic or mucosal routes, 10.1016/0264-410x(95)00016-t
  46. Muszkat M., Yehuda A. Ben, Schein M.H., Friedlander Y., Naveh P., Greenbaum E., Schlesinger M., Levy R., Zakay-Rones Z., Friedman G., Local and systemic immune response in community-dwelling elderly after intranasal or intramuscular immunization with inactivated influenza vaccine, 10.1002/(sici)1096-9071(200005)61:1<100::aid-jmv16>;2-5
  47. Renegar K. B., Small P. A., Boykins L. G., Wright P. F., Role of IgA versus IgG in the Control of Influenza Viral Infection in the Murine Respiratory Tract, 10.4049/jimmunol.173.3.1978
  48. Mazanec Mary B., Lamm Michael E., Lyn Deborah, Portner Allen, Nedrud John G., Comparison of IgA versus IgG monoclonal antibodies for passive immunization of the murine respiratory tract, 10.1016/0168-1702(92)90063-f
  49. Brandtzaeg Per, Role of secretory antibodies in the defence against infections, 10.1078/1438-4221-00241
Bibliographic reference Minne, Antoine ; Louahed, Jamila ; Mehauden, Sybille ; Baras, Benoît ; Renauld, Jean-Christophe ; et. al. The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response. In: Immunology, Vol. 122, no. 3, p. 316-325 (2007)
Permanent URL